Amnesty International and partners have expressed serious concerns regarding the position of theEuropean Commission on efforts to increase access to COVID-19 vaccines, treatments, and othermedical goods by means of a temporary waiver of certain provisions of the Trade Related Aspects ofIntellectual Property Rights (TRIPS) Agreement.
Amnesty held candle lit vigil in Porto on 6 May ahead of EU- India Leaders’ meeting – IMAGES AND FOOTAGE Spokespeople available Ahead of the EU- India Leaders’ meeting on 8 May, Amnesty International is calling on EU leaders to urge India to protect the rights to life and health and to raise the alarm…
In response to the US government’s announcement of its support for waiving intellectual property rights for COVID-19 vaccines, Amnesty International’s Eve Geddie, Director of Amnesty International’s EU Office said: “Today, Europe wakes up to a new political reality that its position on hoarding the rights to make COVID-19 vaccines is now untenable. It is time…
EU leaders meeting in Portugal next weekend will have online talks with Indian Prime Minister Modi. India currently faces a wave of COVID-19 infections and shortages of vaccines and treatments such as oxygen. At the same time, critics of India’s pandemic response are being silenced – including on Twitter and Facebook. This is why human…
The European Commission and European Union (EU) Member States continue to ignore growing calls for a patent waiver that would increase global production and availability of COVID-19 vaccines and related equipment. Recently, nearly 400 Members of the European Parliament (MEPs) and of national Parliaments from across the EU signed a joint appeal expressing their unequivocal…